Gilead Sciences Ten years after the start of the program, which developed the program with an annual investment of one million euros, it distributed its scholarships.
in cooperation with Carlos III Institute of Health (ISCIII) 43 projects were selected in the fields of HIV, covid-19, Viral Hepatitis C and Delta, Invasive Fungal Infection, Hemato-oncology and Medical Oncology.
These scholarships are already one of the programs. Biomedical R&D The most relevant in Spain.
Since the start of this scholarship program, the company has supported 166 projects. In addition, 9 new works were presented for the third consecutive edition. young researchers
“These scholarships are a demonstration of our commitment. Gilead It was created with the aim of supporting the research work and promoting the experience and talents of Spanish scientists in fields where medical needs still need to be met,” he said.
“The Gilead Biomedical Research Fellowships are a prime example of our commitment to innovation and biomedical research in Spain. For ten years they have served to support initiatives that allow evidence generation and progress in improving patients’ health. This program is a true benchmark for Spanish researchers and excellence and quality We are particularly proud of the projects presented. “Through these fellowships, we are helping to increase knowledge in areas where there are still unmet medical needs, fully in line with our company’s mission,” said María Río, Vice President and Managing Director of Gilead Spain.
Award-winning projects
Selection of award-winning projects, Carlos III Institute of Health (ISCIII), an organization that guarantees the independence and transparency of this competition and contributes with its experience and international network of evaluators. According to its director, Cristóbal Belda, “ Carlos III Institute of Health As a sign of our commitment to science and knowledge generation to improve human health, we will always support two-way initiatives such as these Gilead grants that promote biomedical and health research and make public-private collaboration a useful tool. “.
this Minister of HealthCarolina Darias was responsible for closing the awards ceremony for the eighth and ninth of these fellowships, emphasizing the importance of promoting R&D in Spain.
The competition was held with the cooperation and support of Turkey. Spanish Society of Infectious Diseases and Clinical Microbiology (Seimc) and his AIDS Working Group (GeSIDA), Spanish Liver Studies Association (AEEH), Spanish Society of Hematology and Hemotherapy (SEHH), Seimc Medical Mycology Working Group (Gemicomed) and Spanish Society of Medical Oncology (SEOM).
Spanish Medicines Agency
Gilead also wanted to pay tribute to the Spanish Agency for Medicines and Healthcare Products (Aemps), the General Council of Official Physician Colleges (Cgcom), the General Council of Schools of Pharmacy (CGCF) and the General Nursing Council of Spain (CGE). ) for their contributions, efforts and dedication during Pandemic“Decisive in response to SARS-CoV-2”.
#Gilead #Sciences #awards #fellowships #collaboration #Carlos #III #Institute #Health